![](/img/cover-not-exists.png)
Cognitive function did not improve after initiation of natalizumab treatment in relapsing-remitting multiple sclerosis. A prospective one-year dual control group study
Sundgren, M., Piehl, Fredrik, Wahlin, Åke, Brismar, TomVolume:
10
Language:
english
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2016.08.011
Date:
November, 2016
File:
PDF, 540 KB
english, 2016